Frank Takkinen
Stock Analyst at Lake Street
(0.92)
# 3,979
Out of 5,152 analysts
75
Total ratings
26.47%
Success rate
-15.89%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $22.63 | +120.95% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.33 | +351.81% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.78 | -26.78% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $11.11 | +260.04% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.66 | +71.86% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $3.96 | +203.03% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $29.16 | +37.17% | 2 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.97 | +312.37% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $0.85 | +254.23% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.61 | +148.45% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.11 | +440.54% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $2 | $1.10 | +82.65% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $62.46 | +140.15% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.87 | +120.79% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $8.37 | +67.26% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $12.21 | +22.85% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $15.19 | +71.17% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $9.25 | +224.32% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.33 | +215.96% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.64 | +204.88% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $37.86 | -20.76% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.69 | +765.30% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.19 | +82.65% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $13.60 | -11.76% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.28 | +174.62% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.25 | +276.47% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $10.41 | +2,559.94% | 2 | Jan 18, 2023 |
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $22.63
Upside: +120.95%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.33
Upside: +351.81%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.78
Upside: -26.78%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $11.11
Upside: +260.04%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.66
Upside: +71.86%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $3.96
Upside: +203.03%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $29.16
Upside: +37.17%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.97
Upside: +312.37%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.85
Upside: +254.23%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.61
Upside: +148.45%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.11
Upside: +440.54%
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.10
Upside: +82.65%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $62.46
Upside: +140.15%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.87
Upside: +120.79%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $8.37
Upside: +67.26%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.21
Upside: +22.85%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $15.19
Upside: +71.17%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $9.25
Upside: +224.32%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $6.33
Upside: +215.96%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.64
Upside: +204.88%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $37.86
Upside: -20.76%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.69
Upside: +765.30%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.19
Upside: +82.65%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $13.60
Upside: -11.76%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.28
Upside: +174.62%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.25
Upside: +276.47%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $10.41
Upside: +2,559.94%